Koers Innovus Pharmaceuticals Inc Other OTC
Aandelen
US45778V1061
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01-06-18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,32% | 684 mld. | |
+29,55% | 568 mld. | |
-3,79% | 361 mld. | |
+18,44% | 329 mld. | |
+4,54% | 284 mld. | |
+16,06% | 240 mld. | |
+9,39% | 208 mld. | |
-6,99% | 200 mld. | |
+7,79% | 166 mld. |